The consensus process was applied to addressing a public health topic; this was a novel endeavor. The following question was addressed: What role, if any, should sentinel health events play in the decision-making process for identifying the effects of environmental exposure? The panel developed three levels ofsentind health events lists: those that are clearly identifiable, those that are potential signs, and those that are indicators ofbody burdens. Additionally, the panel developed several salient statements regardig the principles of envnmental health suvilance and, especialy, reommendations for future research.
Introduction
During October 30-November 1, 1989, a panel of individuals skilled in avariety ofenvironmental health fields met in Asheville, North Carolina. Each ofthe panelists has a professional interest in preventing the adverse human health effects that result from environmental contamination. The objective ofthis meeting was to examine critically the use of sentinel health events as an approach for improving the capability for public health response. This conference was designed as a sequel to the 10th BiraudMacJannet Seminar in Veyrier-du-Lac, France (May 4-6, 1988) , which revealed among other things the inadequacies of traditional health reporting systems.
The Panel was asked to address four questions and believes that this paper is generally responsive to those questions. The questions were: a) What The Panel derived its formulation of sentinel health events from concepts articulated by Rutstein et al. (1) . That work, however, focused exclusively on occupational exposures and on individual cases with specific and preventable etiologies. In adapting these concepts to general environmental settings, the Panel emphasized nonoccupational exposures and extended the idea of single-case sentinel health events to include certain patterns ofhealth effects and chemical body burdens within populations that may suggest environmental origins.
The Panel decided a) not to include occupationally related sentinel health events that are reported elsewhere; b) not to consider indices of contamination of the ambient environment as such. This exclusion applies to effects found in animals, fish, and vegetation; c) to provide a list of events or measures that is not exhaustive but may be suggestive of criteria that can be used to select such measures; d) to include events or possible reactions regardless ofwhether data systems are currently available to collect such information; and e) not to address the role ofsmoking, drinking, drug use, or radiation, either alone or as factors that aggravate the effects of environmental exposures. These considerations were considered to be beyond the scope ofthe Panel's deliberations.
The Panel was concerned with the extent to which environmental contamination may cause adverse health effects in humans. Answering this question is greatly complicated by a) our present ability to define potential exposure precisely or to measure doses accurately; b) the long and variable latency periods for effects associated with most environmental exposures; c) the relative rarity ofmost environmentally related diseases; d) the nonspecificity of most potential outcomes. Only rarely can one attribute delayed health events to a particular exposure strictly on the basis ofclinical features; e) the possibility that multiple factors may interact;f) and inadequate health data systems.
In the face of these uncertainties an urgent need exists for systematic guidance by which an association between environmental exposures and health outcomes can be evaluated. This guidance can be served by surveillance ofSHEs with the objective ofavoiding unnecessary disease, disability, and premature death consequent to environmental exposures. Ideally, SHEs would be specific for particular environmental exposures; occur shortly after exposure; identified through simple, inexpensive, and well-standardized methods; identified through existing health surveillance mechanisms such as vital records, hospital discharge data, disease registeries; and capable of leading to preventive action.
The first category of indicators identified by the Pafiel refers to individual events that may occur in only one person but may also affect many exposed individuals. The latter categories reflect events that may affect whole populations.
Conclusions
Category I. Clearly Identifiable, Environmentally
Caused SHEs
The Panel considered a wide range ofpotential SHEs, none of which fit the entire set ofideal criteria for this category (specificity, short latency, ease of identification). Examples that most closely fit the criteria are described below and include several acute environmental exposures and two cancers.
Poisoning (pesticides, toxic gases, heavy metals, solvents, chemical spills). Poisonings produce short latency effects from high-dose exposures, but some have long-term effects. In community settings, they may signal wider exposures that require public health action. They are identifiable through medical record sources (hospitals, emergency rooms, poison control centers, physician notifications).
Methemoglobinemia. Methemoglobinemia is subacute or chronic condition, usually manifest in infants, resulting from excessive nitrate levels in drinking water. Public health identification requires access to medical records in hospitals or through physicians.
Mesothelioma. Mesothelioma is a rare form ofcancer of the lining membranes of the thoracic or abdominal cavity and is largely specific for asbestos exposure, independent ofcigarette smoking, and sometimes arises in settings of nonoccupational exposure where the degreeofexposure may notbe extensive. The tumor can be identified through existing tumor registries and medical records, although not very reliably through death certificates. Latency usually exceeds 20 years.
Hepatic angiosarcoma. Hepatic angiosarcoma is a rare liver cancer in humans that is attributable to a considerable degree to vinyl chloride monomer exposure. No cases of angiosarcoma have yet been attributed unequivocally to nonoccupational, environmental contamination with vinyl chloride. However, any case of angiosarcoma should alert public health officials and health care providers to a possible environmental source, which may include arsenic and thorium in addition to vinyl chloride. Angiosarcoma can be identified with some reliability in tumor registries and through medical record systems but not in vital records. Latency is long (10-30 years).
The Panel also discussed SHEs in a broader environmental context. This extended beyond chemical contaminants and encompassed physical environmental stresses such as noise and extreme weather conditions, as well as certain infectious diseases, commonly food or waterborne. Although such considerations were beyond the specific focus ofthe Panel, the continuing need for public health departments to address environmental concerns over a wide spectrum of etiologies should be recognized.
Category II. Potential Signs of Population Exposure to Environmental Contaminants
The adverse health events listed below are not necessarily attributable to environmental contamination because they occur at some background rate or level in the general population among persons with little exposure to environmental pollutants. However, when these events occur in a population at a higher rate than expected, the excess should serve as a warning sign that environmental exposures may account for some ofthe excess. To serve as warning signs, therefore, the rates ofthese events must be compared in both exposed and nonexposed groups or ina population beforeandaftertheintroductionofanenvironmentalcontaminant.
The occurrence ofone ofthese events in an individual is not an SHE. But an excess frequency ofone ofthese events in a population may be a useful indicator ofundue exposure to environmental contamination.
These events may be divided into three groups based on the accessibility ofthedata (Table 1) . Responses identifiedinlists B and CofTable 1 includepreclinical indicatorsofadversehealtheffects, and as such, may be among the most sensitive and early responses to environmental contamination. They may be particularly useful in studies thatcompare baseline or pre-exposure, conditions with postexposure changes, and in studies that seek to determine whether subtle effects havebeen induced inapopulation by the introductionofa new sourceofenvironmental contamination, such as a hazardous waste treatment facility. They require special surveys because such dataare not routinely obtained inclinical settings. It aZPT, zinc protoporphyrin, an easily measured metabolite involved with the structural materials of hemoglobin. Lead impairs the use of ZPT and hence elevated ZPT in screening tests indicates a likelihood of a lead body burden.
bCholinesterase is an enzyme that is specifically blocked by organophosphate pesticides, and a decrease in cholinesterase may reflect a relatively recent exposure to such pesticides.
cAdducts are combinations of pollutants with one or more molecules in the body, such as DNA or hemoglobin, which tend to persist and can be detected at very low concentrations.
usually be available from ordinary health data sources but will require special surveys directed at specific hypotheses (Table 2 ). An example might be a person with a blood lead level of 25 ztg/1OO g, when unexposed persons have 12 ztg/1OO g. The exposed person is said to have a body burden of lead. This third category is used to reflect the occurrence ofan environmental exposure and the absorption of a detectable dose by an individual. A single occurrence could serve as an SHE.
